Koyfin Home > Directory > Health Care > Acceleron Pharma > Cost of Goods Sold

Acceleron Pharma Cost of Goods Sold Chart (XLRN)

Acceleron Pharma annual/quarterly Cost of Goods Sold from 2012 to 2020.
  • Acceleron Pharma Cost of Goods Sold for the quarter ending June 06, 2020 was $38m a 1.62% increase of 1m year over year
  • Acceleron Pharma Cost of Goods Sold for the last 12 months ending June 06, 2020 was $162m a 16.84% increase of 27m year over year
  • Acceleron Pharma Annual Cost of Goods Sold for 2019 was $154m a 32.51% increase of 50m from 2018
  • Acceleron Pharma Annual Cost of Goods Sold for 2018 was $104m a 13.64% increase of 14m from 2017
  • Acceleron Pharma Annual Cost of Goods Sold for 2017 was $90m a 27.80% increase of 25m from 2016
Other Income Statement Metrics:
  • Acceleron Pharma EBITDA for the quarter ending December 12, 2018 was $-36m a 25.58% decrease of -9m year over year
  • Acceleron Pharma Net Income for the quarter ending December 12, 2018 was $-35m a 24.52% decrease of -9m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Cost of Goods Sold Data

06/2020$38m
03/2020$38m
12/2019$49m
09/2019$38m
06/2019$35m
03/2019$33m
12/2018$30m
09/2018$25m
06/2018$26m
03/2018$23m

Annual XLRN Cost of Goods Sold Data

2019$154m
2018$104m
2017$90m
2016$65m
2015$55m
2014$48m
2013$36m
2012$35m
2011$34m